Insights

Synopsis of Draft Guidance on Health Canada’s T&Cs

Foreign action notification to Health Canada

Quality, regulatory, safety: Meeting a collective compliance need

Navigating the new era of Canadian medical device regulations: What MDEL holders need to know

Key insights from RAPS Convergence 2025

Navigating Canadian environmental regulations: A case study on NSNR compliance

What you need to know about renewing your Drug Establishment Licence (DEL)

Understanding XML Product Monographs

Case Study: Optimizing Procedures - Achieving Excellence in Medical Device Management

Pharmacovigilance: Canadian requirements

Webinar on-demand - A Panel Discussion on Navigating Medical Devices in Canada

Manufacturers

Drug development checklist: what to look for in a commercialization partner

Manufacturers

Pre-launch checklist: what to look for in a commercialization partner

Manufacturers

Post launch checklist: what to look for in a commercialization partner

Manufacturers

InnomarLive 2023: Part One

Manufacturers

InnomarLive 2023: Part Two

Manufacturers

InnomarLive 2023: Part Three

Manufacturers

Regulatory Services: Management and Control of Certified Product Information Document

Manufacturers

Webinar: Impact of COVID-19 on Patient Support Programs in Canada

Manufacturers

Case Study: Launching a new molecule for a rare disease

Manufacturers

Case Study: A proven approach for an emerging specialty pharma company

Manufacturers

Case Study: A flexible solution for launching a new molecule in oncology

Manufacturers

The value of Real-World Evidence in Canadian drug commercialization: Part 2

Manufacturers

Webinar: Utilizing Real World Evidence Across the Product Life Cycle

Manufacturers

Commercializing in Canada: Quality Assurance and GMP Services

Manufacturers

Commercializing in Canada: Regulatory Publishing and Submissions

Manufacturers

Webinar: Health Canada’s Regulatory and Quality approach to addressing COVID-19 challenges